200 related articles for article (PubMed ID: 18674638)
1. Targeting insulin and insulin-like growth factor signalling in oncology.
Pollak M
Curr Opin Pharmacol; 2008 Aug; 8(4):384-92. PubMed ID: 18674638
[TBL] [Abstract][Full Text] [Related]
2. Insulin and insulin-like growth factor signalling in neoplasia.
Pollak M
Nat Rev Cancer; 2008 Dec; 8(12):915-28. PubMed ID: 19029956
[TBL] [Abstract][Full Text] [Related]
3. The insulin receptor/insulin-like growth factor receptor family as a therapeutic target in oncology.
Pollak M
Clin Cancer Res; 2012 Jan; 18(1):40-50. PubMed ID: 22215905
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.
Hua H; Kong Q; Yin J; Zhang J; Jiang Y
J Hematol Oncol; 2020 Jun; 13(1):64. PubMed ID: 32493414
[TBL] [Abstract][Full Text] [Related]
5. Insulin-Like Growth Factor (IGF) family and prostate cancer.
Gennigens C; Menetrier-Caux C; Droz JP
Crit Rev Oncol Hematol; 2006 May; 58(2):124-45. PubMed ID: 16387509
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential.
Bieghs L; Johnsen HE; Maes K; Menu E; Van Valckenborgh E; Overgaard MT; Nyegaard M; Conover CA; Vanderkerken K; De Bruyne E
Oncotarget; 2016 Jul; 7(30):48732-48752. PubMed ID: 27129151
[TBL] [Abstract][Full Text] [Related]
7. Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
You L; Liu C; Tang H; Liao Y; Fu S
Curr Pharm Des; 2014; 20(17):2899-911. PubMed ID: 23944362
[TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor pathway as a target for cancer therapy.
López-Calderero I; Sánchez Chávez E; García-Carbonero R
Clin Transl Oncol; 2010 May; 12(5):326-38. PubMed ID: 20466617
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions.
Gualberto A; Pollak M
Oncogene; 2009 Aug; 28(34):3009-21. PubMed ID: 19581933
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer.
Massoner P; Ladurner-Rennau M; Eder IE; Klocker H
Br J Cancer; 2010 Nov; 103(10):1479-84. PubMed ID: 20924377
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor 1 receptor in cancer: old focus, new future.
Hartog H; Wesseling J; Boezen HM; van der Graaf WT
Eur J Cancer; 2007 Sep; 43(13):1895-904. PubMed ID: 17624760
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer.
Philippou A; Christopoulos PF; Koutsilieris DM
Mutat Res Rev Mutat Res; 2017; 772():105-122. PubMed ID: 28528684
[TBL] [Abstract][Full Text] [Related]
13. Targeting the insulin-like growth factor network in cancer therapy.
Heidegger I; Pircher A; Klocker H; Massoner P
Cancer Biol Ther; 2011 Apr; 11(8):701-7. PubMed ID: 21311212
[TBL] [Abstract][Full Text] [Related]
14. Insulin, insulin-like growth factors and neoplasia.
Pollak M
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):625-38. PubMed ID: 18971123
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of inhibitors of the insulin-like growth factor receptor in oncology.
Gualberto A; Pollak M
Curr Drug Targets; 2009 Oct; 10(10):923-36. PubMed ID: 19663769
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of agents targeting the type I insulin-like growth factor receptor.
Zhang H; Yee D
Expert Opin Investig Drugs; 2004 Dec; 13(12):1569-77. PubMed ID: 15566314
[TBL] [Abstract][Full Text] [Related]
17. Targeting insulin-like growth factor in breast cancer therapeutics.
Karamouzis MV; Papavassiliou AG
Crit Rev Oncol Hematol; 2012 Oct; 84(1):8-17. PubMed ID: 22424863
[TBL] [Abstract][Full Text] [Related]
18. Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.
Maki RG
J Clin Oncol; 2010 Nov; 28(33):4985-95. PubMed ID: 20975071
[TBL] [Abstract][Full Text] [Related]
19. Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.
Hendrickson AW; Haluska P
Curr Opin Investig Drugs; 2009 Oct; 10(10):1032-40. PubMed ID: 19777391
[TBL] [Abstract][Full Text] [Related]
20. [The role of insulin-like growth factors (IGF) in cell division processes and in malignancy].
Vasas P; Winslet MC; Shi YY
Orv Hetil; 2009 Dec; 150(51):2308-12. PubMed ID: 19995694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]